share_log

中基健康(000972.SZ)：终止实施2023年限制性股票激励计划

Chalkis Health Industry (000972.SZ): Terminates the implementation of the 2023 restricted stock incentive plan.

Gelonghui Finance ·  Aug 21 07:25

Chalkis Health Industry (000972.SZ) announced on August 21st that the purpose of launching the restricted stock incentive plan for 2023 is to further establish and improve the company's long-term incentive mechanism, attract and retain outstanding talents, effectively combine the interests of shareholders, the company, and the core team, and collectively focus on the long-term development of the company, bringing sustainable returns to shareholders. It advocates the concept of continuous development of the company and individuals, builds a community of interests among shareholders, the company, and employees, mobilizes the enthusiasm of core talents, and promotes the long-term and stable development of the company. It establishes a compensation incentive system that combines short-term and long-term incentives through various means such as salary and equity, focusing on the long-term value of the company, shareholder value, and talent value for win-win results. Considering the current market environment, the company's operation situation, and fluctuations in the company's stock price, the company has decided to terminate the implementation of the restricted stock incentive plan for 2023, including all related documents that are associated with it.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment